Skip to main content
SpringerLink
Log in

Is it dexfenfluramine or weight loss that reduces blood pressure and noradrenergic activity in obese patients?

  • Letters to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kolanowski J, Younis LT, Vanbutsele R, Detry J-M (1992) Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients. Eur J Clin Pharmacol 42: 599–606

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Hôpital Pitié-Salpêtrière, 47-83 Boulevard de l'Hôpital, F-75651, Paris Cedex 13, France

    I. Berlin & A. J. Puech

Authors
  1. I. Berlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. J. Puech
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berlin, I., Puech, A.J. Is it dexfenfluramine or weight loss that reduces blood pressure and noradrenergic activity in obese patients?. Eur J Clin Pharmacol 44, 601 (1993). https://doi.org/10.1007/BF02440870

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02440870

Key words

Search

Navigation